Enhance the willingness of healthcare workers to be vaccinated against COVID-19 in Germany

德国期待已久的首个COVID-19疫苗获得批准，以控制COVID-19大流行。特别是在养老院和医院，接种疫苗可以保证与COVID-19患者接触的医护人员的安全。Willi-Vacc项目旨在确定干预措施，以提高德国医护人员接种COVID-19疫苗的意愿。william - vacc的研究目标是：1。将有关干预措施的证据纳入范围，以提高普通人群接种COVID-19疫苗的意愿（Cochrane综述）。我们将首先进行系统的范围审查，以确定干预措施，提高普通人群接种COVID-19疫苗的意愿。与利益攸关方（利益攸关方会议）一起对范围审查中发现的与卫生保健工作者相关的干预措施进行优先排序。一旦范围审查完成，我们计划与以下团体的代表举行利益相关者在线会议：•Ständige impfcommission （STIKO）•罗伯特·科赫研究所（RKI）•世界卫生组织（WHO）•bundeszentrale f<s:1> gesundheitliche Aufklärung （BZgA）•德意志Berufsverband f<e:1> (DBfK)•德意志Berufsverband f<e:1> (DBfK)•德意志Berufsverband f<e:1> (DBVA)•arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften （AWMF）•疫苗接种中心3。对优先干预措施进行实时系统评价（Cochrane review）。首先，我们将制定并发布Cochrane协议，概述纳入和排除标准以及用于进行活体系统评价和更新的方法。最终的PICO问题将根据涉及利益相关者的优先排序过程确定。如果有随机对照研究（RCTs），我们将纳入它们。在RCT证据不足的情况下，如果没有非对照研究，我们将纳入前瞻性计划的对照研究。第一版综述将在9个月后发表（计划命名为Cochrane review）。我们期待在这个快速发展的领域有许多新的研究，计划在12个月后更新。与利益相关者（利益相关者会议）讨论德国卫生保健工作者干预策略的实施情况。为了在德国实施审查结果和审查更新，我们计划与利益相关者小组再举行两次会议。

The approval of the first COVID-19 vaccine has been long-awaited in Germany to control the COVID-19 pandemic. Especially in nursing homes and hospitals, the vaccination could guarantee the safety of healthcare workers in contact with COVID-19 patients. The Willi-Vacc project aims to identify interventions to enhance the willingness of German healthcare workers to be vaccinated against COVID-19. The research objectives of Willi-Vacc are to:1. Scope the evidence on interventions to enhance willingness to be vaccinated against COVID-19 among the general population (Scoping Cochrane Review). We will start with a systematic scoping review to identify interventions to enhance willingness to be vaccinated against COVID-19 among the general population.2. Prioritise the interventions for their relevance to healthcare workers found in the scoping review together with stakeholders (Stakeholder meeting).Once the scoping review is finalised, we plan a stakeholder online meeting with representatives from the following groups:• Ständige Impfkommission (STIKO)• Robert Koch Institut (RKI)• World Health Organisation (WHO)• Bundeszentrale für gesundheitliche Aufklärung (BZgA)• Deutscher Berufsverband für Pflegeberufe (DBfK)• Deutscher Berufsverband für Altenpflege e.V (DBVA)• Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)• Vaccination centers3. Conduct a living systematic review of the prioritised interventions (Cochrane Review).First, we will develop and publish a Cochrane protocol, outlining the inclusion and exclusion criteria and methods being used to conduct the living systematic review and the update. The final PICO questions will be determined based on the prioritisation process involving the stakeholders. If randomised controlled studies (RCTs) are available, we will include them. In case of insufficient RCT evidence, we will include prospectively planned controlled studies, if not available uncontrolled studies. The first version of the review will be published after nine months (planned as Cochrane Review). As we expect many new studies in this rapidly evolving field, an update after 12 months is planned.4. Discuss the implementation of the intervention strategies for healthcare workers in Germany with stakeholders (Stakeholder meeting).To implement the findings of the review and review updates in Germany we plan two further meetings with the stakeholder panel.